SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-009306
Filing Date
2021-05-06
Accepted
2021-05-06 16:14:11
Documents
78
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q auph-20210331.htm   iXBRL 10-Q 968193
2 EX-31.1 auph-20210331xexx311.htm EX-31.1 10963
3 EX-31.2 auph-20210331xexx312.htm EX-31.2 11105
4 EX-32.1 auph-20210331xexx321.htm EX-32.1 5431
5 EX-32.2 auph-20210331xexx322.htm EX-32.2 5439
  Complete submission text file 0001628280-21-009306.txt   5342645

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT auph-20210331.xsd EX-101.SCH 38061
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT auph-20210331_cal.xml EX-101.CAL 78393
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT auph-20210331_def.xml EX-101.DEF 171079
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT auph-20210331_lab.xml EX-101.LAB 478465
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT auph-20210331_pre.xml EX-101.PRE 308996
11 EXTRACTED XBRL INSTANCE DOCUMENT auph-20210331_htm.xml XML 887823
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36421 | Film No.: 21897923
SIC: 2834 Pharmaceutical Preparations